print
Sunitinib for advanced and/or metastatic pancreatic islet cell tumours
- Source agency:
- NHSC
- Date of Submission:
- 02/02/2010
- Date of Printing:
- 10/03/2010
- Technology name:
- Sunitinib
- Technology - type(s):
- Drug
- Patient indications:
- • Pancreatic islet cell tumours: well differentiated advanced and/or metastatic not, amenable to treatment with curative intent.